Literature DB >> 14522629

Henoch-Schönlein purpura following hepatitis B vaccination.

T Chave1, C Neal, R Camp.   

Abstract

The use of recombinant hepatitis B vaccines has led to the effective prevention of hepatitis B infection and its chronic sequelae in immunocompetent individuals. Whilst rare, a variety of serious adverse effects have been reported following vaccination including cutaneous vasculitis in eight previous cases. We describe a case of Henoch-Schönlein purpura developing after hepatitis B vaccination.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14522629     DOI： 10.1080/09546630310004199

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


  4 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

3.  Successful treatment of gastrointestinal involvement in Henoch-Schönlein purpura with plasmapheresis.

Authors:  Banu Acar; F Inci Arikan; Bulent Alioglu; Nergis Oner; Yildiz Dallar
Journal:  Pediatr Nephrol       Date:  2008-06-11       Impact factor: 3.714

4.  The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers.

Authors:  Jeffrey S Kennedy; Mary Co; Sharone Green; Karen Longtine; Jaclyn Longtine; Melissa A O'Neill; Janice P Adams; Alan L Rothman; Qiao Yu; Renita Johnson-Leva; Ranajit Pal; Shixia Wang; Shan Lu; Phillip Markham
Journal:  Vaccine       Date:  2008-06-25       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.